US67066Y1055

Taking everything into account, **NAC** scores **2** out of 10 in our fundamental rating. **NAC** was compared to 0 industry peers in the **Unkown** industry. **NAC** may be in some trouble as it scores bad on both profitability and health. **NAC** has a expensive valuation and it also scores bad on growth.

In the past year **NAC** has reported negative net income.

In multiple years **NAC** reported negative net income over the last 5 years.

Each year in the past 5 years **NAC** had a positive operating cash flow.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.14% | ||

ROE | -1.95% | ||

ROIC | 0.34% |

ROA(3y)-3.61%

ROA(5y)0.06%

ROE(3y)-6.03%

ROE(5y)-0.15%

ROIC(3y)N/A

ROIC(5y)N/A

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 16.44% | ||

PM (TTM) | N/A | ||

GM | 17.16% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **NAC** remains at a similar level compared to 1 year ago.

The debt/assets ratio for **NAC** is higher compared to a year ago.

Based on the Altman-Z score of **0.71**, we must say that **NAC** is in the distress zone and has some risk of bankruptcy.

The Debt to FCF ratio of **NAC** is **12.37**, which is on the high side as it means it would take **NAC**, **12.37** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.70** indicates that **NAC** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | 12.37 | ||

Altman-Z | 0.71 |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.2 | ||

Quick Ratio | 2.2 |

The **Revenue** has grown by **26.43%** in the past year. This is a very strong growth!

The Revenue for **NAC** have been decreasing by **-35.14%** on average. This is quite bad

EPS 1Y (TTM)90.73%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q100.58%

Revenue 1Y (TTM)26.43%

Revenue growth 3Y-50.39%

Revenue growth 5Y-35.14%

Revenue growth Q2Q20313.33%

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.42 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.83% |

The dividend of **NAC** decreases each year by **-5.57%**.

Dividend Growth(5Y)-5.57%

Div Incr Years0

Div Non Decr Years0

The earnings of **NAC** are negative and hence is the payout ratio. **NAC** will probably not be able to sustain this dividend level.

DP-203.46%

EPS Next 2YN/A

EPS Next 3YN/A

**NUVEEN CA QUAL MUNI INC FD**

NYSE:NAC (12/8/2023, 7:06:09 PM)

After market: 10.7 -0.04 (-0.37%)**10.74**

**0 (0%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.55B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.83% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.14% | ||

ROE | -1.95% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 16.44% | ||

PM (TTM) | N/A | ||

GM | 17.16% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.7 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.2 | ||

Quick Ratio | 2.2 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)90.73%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)26.43%

Revenue growth 3Y-50.39%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y